德英生物科技

Important resolutions of the Board of Directors in 2021

Important Resolutions of the Board of Directors in 2021 (Year 110)

▌Note: The table can be scrolled horizontally
Date Main Agenda Resolution
2021.03.12 Agenda 1: The Company’s 2020 Financial Statements submitted for review. With no objection from all attending directors, the proposal was approved. After accountants 林永智 and 田中玉 of PwC Taiwan complete the audit and certification of the 2020 financial statements, the case will be submitted to the shareholders’ meeting for acknowledgment.
Agenda 2: The Company’s 2020 Business Report and Statement of Loss Compensation submitted for discussion. The proposal was approved with no objections and will be submitted to the shareholders’ meeting for acknowledgment.
Agenda 3: Completion of the Company’s 2020 Internal Control Self-Assessment and issuance of the Internal Control System Statement submitted for discussion. The proposal was approved with no objections from all attending directors.
Agenda 4: Amendments to the Company’s “Rules of Procedure for Shareholders’ Meetings” submitted for discussion. The amendments to the “Rules of Procedure for Shareholders’ Meetings” were approved with no objections from all attending directors and will be included in the agenda of the upcoming Annual Shareholders’ Meeting.
Agenda 5: Arrangements for convening the 2021 Annual Shareholders’ Meeting submitted for discussion. The proposal was approved with no objections from all attending directors.
2021.05.07 Agenda 1: Engagement of PwC Taiwan to conduct the 2021 financial statement audit, corporate income tax filing, and full-time non-managerial salary information submission submitted for discussion. The proposal was approved with no objections from all attending directors.
2021.08.06 Agenda 1: Recognition of the renewal of Directors’ Liability Insurance for 2021 submitted for discussion. The proposal was approved with no objections from all attending directors.
Agenda 2: Matters related to postponing the convening of the 2021 Annual Shareholders’ Meeting in accordance with regulations submitted for discussion. The proposal was approved with no objections from all attending directors.
2021.11.05 There were only reporting items in this meeting and no discussion items.
2021.12.24 Agenda 1: Establishment of the Company’s 2022 Budget submitted for discussion. The Company’s 2022 Budget was approved with no objections from all attending directors.
Agenda 2: Establishment of the Company’s 2022 Audit Plan submitted for discussion. The Company’s 2022 Audit Plan was approved with no objections from all attending directors.
Agenda 3: Establishment of the Company’s “Guidelines for the Appointment, Dismissal, Performance Evaluation, and Compensation of Internal Auditors” submitted for discussion. The Company’s “Guidelines for the Appointment, Dismissal, Performance Evaluation, and Compensation of Internal Auditors” were approved with no objections from all attending directors.